- FDA grants priority review for new oral gonorrhea antibiotic CIDRAP
- FDA Grants Priority Review for Gepotidacin for Gonorrhea Contagion Live
- GSK opens higher after priority review for new gonorrhoea pill Proactive financial news
- GSK’s Gepotidacin Gains Priority Review for Gonorrhoea Treatment TipRanks
- GSK’s oral antibiotic for gonorrhoea set for FDA review Yahoo Finance
FDA grants priority review for new oral gonorrhea antibiotic – CIDRAP
